학술논문

Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Document Type
Article
Source
In Clinical Gastroenterology and Hepatology October 2020 18(11):2544-2553
Subject
Language
ISSN
1542-3565